5 results match your criteria: "The Ex-Vivo Research Centre[Affiliation]"
Front Surg
May 2022
The Ex-Vivo Research Centre CIC, Alderley Park, Macclesfield, United Kingdom.
Twenty years have surpassed since the first vascularised composite allotransplantation (VCA) of the upper limb. This is an opportunity to reflect on the position of VCA as the gold standard in limb reconstruction. The paucity of recipients, tentative clinical outcomes, and insufficient scientific progress question whether VCA will remain a viable treatment option for the growing numbers of amputees.
View Article and Find Full Text PDFASAIO J
April 2022
From the The Ex-Vivo Research Centre, 3F66, Block 3, Alderley Park, Nether Alderley, Cheshire, United Kingdom.
There has been significant progress in the development of ex vivo machine perfusion for the nonischemic preservation of donor organs. However, several complications remain, including the logistics of using human blood for graft oxygenation and hemolysis occurring as a result of mechanical technology. Recently, hemoglobin-based oxygen carriers, originally developed for use as blood substitutes, have been studied as an alternative to red blood cell-based perfusates.
View Article and Find Full Text PDFFront Med (Lausanne)
January 2022
Oxford Transplant Centre, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
Kidney transplantation is the best renal-replacement option for most patients with end-stage renal disease. Normothermic machine preservation (NMP) of the kidney has been studied extensively during the last two decades and implemented in clinical trials. Biomarker research led to success in identifying molecules with diagnostic, predictive and therapeutic properties in chronic kidney disease.
View Article and Find Full Text PDFArtif Organs
February 2022
The Ex-Vivo Research Centre, Nether Alderley, UK.
Introduction: Recent experimental evidence suggests normothermic machine perfusion of the vascularized composite allograft results in improved preservation compared to static cold storage, with less reperfusion injury in the immediate post-operative period. However, metabolic acidosis is a common feature of vascularized composite allograft perfusion, primarily due to the inability to process metabolic by-products. We evaluated the impact of combined limb-kidney perfusion on markers of metabolic acidosis and inflammation in a porcine model.
View Article and Find Full Text PDFTransplant Rev (Orlando)
April 2021
The Transplant Centre, Manchester University Hospitals NHS Foundation Trust, Manchester M23 9LT, UK; The Ex-Vivo Research Centre, Division of Cell Matrix and Regenerative Medicine, School of Biology, Medicine and Health, Manchester Academic Health Science Centre, Room 1.622 Stopford Building, Oxford Riad, University of Manchester, Manchester M13 9NT, UK. Electronic address:
Sensitisation to human leukocyte antigen (HLA) represents a significant barrier to kidney transplantation. Antibody removal and immune modulation strategies, known as 'desensitisation', aim to reduce levels of circulating HLA antibodies and increase transplant opportunities for highly sensitised patients (HSPs). However, the effects of desensitisation are generally transient and maintaining low or absent HLA antibody levels remains a substantial challenge.
View Article and Find Full Text PDF